Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: A nationwide, population-based cohort study
European Journal of Cancer · 2024
DOI: 10.1016/j.ejca.2024.114025 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift European Journal of Cancer, 2024. Verfasst von Thomas Wagner und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark; Department of Pathology, Copenhagen …. Hauptthemen laut MEDLINE: Testicular Neoplasms, Seminoma. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kræftens Bekæmpelses Center for Kræftforskning, Dansk Kraeftforsknings Fond.
Abstract (Originalsprache)
BACKGROUND: Approximately 30% of patients with clinical stage I non-seminoma (CSI-NS) relapse. Current risk stratification is based on lymphovascular invasion (LVI) alone. The extent to which additional tumor characteristics can improve risk prediction remains unclear. OBJECTIVE: To determine the most important prognostic factors for relapse in CSI-NS patients. DESIGN, SETTING, AND PARTICIPANTS: Population-based cohort study including all patients with CSI-NS diagnosed in Denmark between 2013 and 2018 with follow-up until 2022. Patients were identified in the prospective Danish Testicular Cancer database. By linkage to the Danish National Pathology Registry, histological slides from the orchiectomy specimens were retrieved. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Histological slides were reviewed blinded to the clinical outcome. Clinical data were obtained from medical records. The association between prespecified potential prognostic factors and relapse was assessed using Cox regression analysis. Model performance was evaluated by discrimination (Harrell's C-index) and calibration. RESULTS: Of 453 patients included, 139 patients (30.6%) relapsed during a median follow-up of 6.3 years. Tumor invasion into the hilar soft tissue of the testicular hilum, tumor size, LVI and embryonal carcinoma were independent predictors of relapse. The estimated 5-year risk of relapse ranged from 85%, depending on the number of risk factors. After internal model validation, the model had an overall concordance statistic of 0.75. Model calibration was excellent. CONCLUSION AND RELEVANCE: The identified prognostic factors provide a much more accurate risk stratification than current clinical practice, potentially aiding clinical decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark; Department of Pathology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, D…
- Department of Pathology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.
- Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.
- Department of Pathology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Borgmester Ib Juuls vej 1, 2730 Herlev, Denmark.
- Department of Pathology, Odense University Hospital, J. B. Winsløws vej 15, Winsløwsparken 15, 5000 Odense C, Denmark.
- Department of Oncology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark.
Förderung
- Kræftens Bekæmpelses Center for Kræftforskning
- Dansk Kraeftforsknings Fond
Zitieren
APA
Wagner, T., Toft, B. G., Lauritsen, J., Bandak, M., Christensen, I. J., Engvad, B., Kreiberg, M., Agerbæk, M., Dysager, L., Carus, A., Rosenvilde, J. J., Berney, D., & Daugaard, G. (2024). Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: A nationwide, population-based cohort study. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.114025
Vancouver
Wagner T, Toft BG, Lauritsen J, Bandak M, Christensen IJ, Engvad B, et al. Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: A nationwide, population-based cohort study. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2024.114025
BibTeX
@article{Wagner2024,
author = {Wagner, Thomas and Toft, Birgitte Grønkær and Lauritsen, Jakob and Bandak, Mikkel and Christensen, Ib Jarle and Engvad, Birte and Kreiberg, Michael and Agerbæk, Mads and Dysager, Lars and Carus, Andreas and Rosenvilde, Josephine Julie and Berney, Daniel and Daugaard, Gedske},
title = {Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: A nationwide, population-based cohort study},
journal = {European Journal of Cancer},
year = {2024},
doi = {10.1016/j.ejca.2024.114025}
}
EUVIMED